Investment Manager Bets Proto: Reading the 13F Signal
Institutional moves can illuminate a stock's future. This article unpacks what it means when an investment manager be...
Understanding what stocks are favored by new investors can guide your choices. Explore current buying trends to make informed decisions.
27,622 articlesInstitutional moves can illuminate a stock's future. This article unpacks what it means when an investment manager be...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
A recent SEC 13F shows Midland Wealth Advisors initiating a stake in Bluerock Private Real Estate Fund. Learn why thi...
In a crowded AI field, a defense-focused player shows a different kind of edge: secured access, trusted relationships...
Intuitive Machines stock keeps surprising investors with its steady gains. This guide breaks down the drivers, risks,...
Hims & Hers has shown volatility, but can the stock be undervalued? This guide breaks down the business, key risks, a...
The AI boom is reshaping how businesses buy computing power. This article breaks down two rising cloud players, why t...
A seismic shift in how the Fed communicates could redefine market expectations. This piece examines kevin warsh shift...
Icon stock crushed Wednesday as the CRO leader posted a stronger quarter than expected. We break down what drove the ...
A major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
As SpaceX moves deeper into the public market, investors face a volatile ride. This article lays out credible scenari...